ArticleChina CDC weekly2023
Prevalence and Types of Comorbidities in Pneumoconiosis - China, 2018-2021.
Article in China CDC weekly, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Health inequities in the comorbid association between pneumoconiosis and chronic obstructive pulmonary disease: a nationwide study of age-related heterogeneity.Respiratory research · 2026Article
- Knowledge-attitude-practice of pneumoconiosis prevention and control among Chinese university students: a cross-sectional study.Frontiers in public health · 2026Article
- Pneumoconiosis and Chronic Diseases: A Narrative Review.Iranian journal of public health · 2025Review
- Global and regional burden of pneumoconiosis, 1990-2021: an analysis of data from the global burden of disease study 2021.Frontiers in medicine · 2025Article
- The disease burden of pneumoconiosis in China from 1990 to 2021 and projection to 2050 based on GBD 2021: a cross-sectional study.Frontiers in public health · 2025Article
- Influencing factors of rehabilitation participation among patients with pneumoconiosis in Chongqing, China.Frontiers in medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
What is already known about this topic?: Pneumoconiosis, recognized as one of the most detrimental occupational diseases in China, exhibits a multimorbidity profile due to a plethora of comorbidities and complications. These factors significantly influence the treatment outcomes, progression, prognosis, and overall quality of life of the afflicted patients. What is added by this report?: The present study examined the prevalence and types of comorbidities, encompassing 13 common diseases or conditions, within cases of pneumoconiosis across 27 provincial-level administrative divisions (PLADs) in China. Distinctions in multimorbidity distribution by gender, urban What are the implications for public health practice?: This study serves as a reference point for the formulation of treatment strategies and health policy development concerning pneumoconiosis in China.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.